应用血小板转录组学评估再生障碍性贫血的治疗效果并预测长期血小板计数恢复
该研究采用批量转录组测序分析再生障碍性贫血(AA)患者初诊及不同治疗有效阶段的血小板转录组变化,发现初诊时增殖、红系功能及氨基酸转运相关基因升高,而组蛋白、血小板生成、线粒体能量代谢及信号通路相关基因显著下调;完全缓解后60.6%的差异表达基因显著恢复,纵向样本中鉴定的恢复上升基因可能作为评估治疗效果的生物标志物,且部分缓解患者中恢复上升基因高表达可能提前6个月预测更优的长期血小板计数恢复。
要点
- 初诊AA患者血小板中增殖、红系功能及氨基酸转运相关基因表达升高。
- 完全缓解后60.6%的差异表达基因显著恢复。
- 恢复上升基因可能预测部分缓解患者6个月后的血小板计数恢复。
核心结论
- 血小板转录组发生深刻变化,可能作为评估AA治疗效果和预测长期血小板计数恢复的潜在指标。
研究设计与样本
- 研究采用批量转录组测序分析AA患者初诊及不同治疗有效阶段的血小板转录组变化。
主要发现
- 初诊AA患者中细胞增殖、红系功能及氨基酸转运相关基因升高。
- 初诊AA患者中组蛋白、血小板生成、线粒体能量代谢及信号通路相关基因显著下调。
- 完全缓解后60.6%的差异表达基因显著恢复。
- 纵向样本中鉴定的恢复上升基因可能作为评估治疗效果的生物标志物。
- 部分缓解患者中恢复上升基因高表达可能提前6个月预测更优的长期血小板计数恢复。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Aplastic anemia (AA) is a bone marrow failure disease for which the means of assessing and predicting the therapeutic effectiveness are still relatively limited. Thrombocytopenia is often the earliest and most severe symptom in patients newly diagnosed with AA. While clinical consideration is usually given to the quantitative changes in platelets during treatment, there is little focus on the resolution of the molecular characteristics of platelets in AA. OBJECTIVES: To investigate the changes in platelet molecular characteristics throughout the treatment process of AA, and to explore the use of transcriptomics for monitoring and predicting treatment outcomes. METHODS: We comprehensively analyzed platelet transcriptomic changes in patients with AA at initial diagnosis and different stages of treatment effectiveness using bulk transcriptome sequencing. RESULTS: Genes associated with cell proliferation, erythroid function, and amino acid transport were elevated in newly diagnosed AA. Conversely, genes linked to histones, thrombopoiesis, mitochondrial energy metabolism, and signaling pathways were significantly downregulated. Additionally, 60.6% of the differentially expressed genes were substantially restored following complete remission. Furthermore, through the examination of longitudinal samples, we identified recovery ascending genes that could serve as viable biomarkers for assessing treatment effectiveness in AA. Besides, we observed that higher expression levels of recovery ascending genes may predict superior long-term platelet counts recovery 6 months in advance in patients with partial response. CONCLUSION: The platelet transcriptome undergoes profound changes and can serve as a potential indicator for assessing treatment effectiveness and predicting long-term platelet counts recovery in AA.
引用
- Mao J, Zhao J, Pan H, et al. Application of platelet transcriptomics for assessing treatment effectiveness and predicting long-term platelet counts recovery in aplastic anemia. J Thromb Haemost. 2024. PMID: 39547652. doi:10.1016/j.jtha.2024.10.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。